CD36 and metabolic dysfunction-associated steatotic liver disease: Furthermore, according to a previous study [31], increased mitochondrial CD36 expression leads to more acyl-CoA oxidation by mitochondria in hepatocytes, which contributes to the reduction of lipid accumulation in non-alcoholic fatty liver disease.